Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation

por Cremer, Paul C, Sheng, Calvin C, Sahoo, Debasis, Dugar, Siddharth, Prada, Robier Aguillon, Wang, Tom Kai Ming, Hassan, Ossama K Abou, Hernandez-Montfort, Jamie, Wolinsky, David A, Culver, Daniel A, Rajendram, Prabalini, Duggal, Abhijit, Brennan, Danielle M, Wolski, Katherine E, Lincoff, A Michael, Nissen, Steven E, Menon, Venu
Publicado 2021